Billion
+$ 0
Estimated Cancer Survivors by 2024
+ 0 MIL
Billion cost Savings Opportunities
>$ 0
Estimated New Cases 2024
0

Real-World Evidence Generation Solutions

The most expensive drug is the one that doesn't work in real-world settings.

One Step Ahead

Seeking Better Solutions

Cancer Care Innovations is an established 501(c)(3) organization dedicated to generating real-world evidence to to inform providers, payers, and pharmaceutical manufacturers to optimize patient outcomes.

Recent publications by the National Cancer Institute (NCI), has estimated that total annual costs of cancer care will reach approach ~$250b by 2030 (>20% of the GDP).  The cost of cancer care is increasing exponentially and newly FDA approved targeted therapies costs anywhere from $200,000 to $500,000 per year. More so, there is limited evidence that outcomes in real world are comparable to outcomes projected in pivotal FDA registration trials. 

The RWE Model

A potential Solution to "The Perfect Storm"

We are facing an unprecidented increase in treatment costs.

Our Mission

Making a difference

Connecting Real-World Results to Responsible Pharmaceutical Use

Case Studies & Topics
Coming Soon!

Scroll to Top
Scroll to Top